Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Risk prediction for clonal cytopenia: multicenter real-world evidence

Blood (2024) 144 (19): 2033–2044.

https://doi.org/10.1182/blood.2024024756

Published: 2024

Includes: Supplemental data

Journal Articles

iPSC Reprogramming Identifies the Role of Cryptic Drivers in Preleukemic Clonal Evolution

Blood (2024) 144 (Supplement 1): 1293.

https://doi.org/10.1182/blood-2024-205098

Published: 2024

Journal Articles

Mitotic Dysregulation Sensitizes Malignant Stem Cells to CHK1 Inhibition in SF3B1 -Mutant Myeloid Neoplasms

Martina Sarchi, Courtnee A. Clough, Edie I. Crosse, Jason Kim, Laura D. Baquero Galvis, Anna Gallì, J. Philip Creamer, Sintra Stewart, Sara Pozzi, Elisabetta Molteni, Chiara Elena, Robert K. Bradley, Luca Malcovati, Sergei Doulatov

Blood (2023) 142 (Supplement 1): 313.

https://doi.org/10.1182/blood-2023-188476

Published: 2023

Journal Articles

Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity

Elisabetta Molteni, Elisa Bono, Anna Gallì, Chiara Elena, Jacqueline Ferrari, Nicolas Fiorelli, Sara Pozzi, Virginia Valeria Ferretti, Martina Sarchi, Ettore Rizzo, Virginia Camilotto, Emanuela Boveri, Mario Cazzola, Luca Malcovati

Blood (2023) 142 (7): 643–657.

https://doi.org/10.1182/blood.2022019304

Published: 2023

Includes: Supplemental data

Journal Articles

Clonal Trajectories and Therapeutic Targeting of High-Risk SF3B1 -Mutant Myelodysplastic Syndromes

Martina Sarchi, Courtnee A Clough, Anna Gallì, Gabriele Todisco, J. Philip Creamer, Luca Malcovati, Sergei Doulatov

Blood (2022) 140 (Supplement 1): 211–212.

https://doi.org/10.1182/blood-2022-164833

Published: 2022

Journal Articles

Follow-up Next Generation Sequencing (NGS) Analyses on Clonal Chronic Idiopathic Neutropenia (CIN) Patients: Insights in the Natural History of the Disease

Grigorios Tsaknakis, Stavros Papadakis, Peggy Kanellou, Irene Mavroudi, Irene Fragiadaki, Charalampos Pontikoglou, Anna Gallì, Luca Malcovati, Helen A. Papadaki

Blood (2021) 138 (Supplement 1): 987.

https://doi.org/10.1182/blood-2021-151131

Published: 2021

Journal Articles

Modeling Clonal Progression in SF3B1 -Mutant Myelodysplastic Syndrome

Martina Sarchi, Anna Gallì, Courtnee A Clough, Gabriele Todisco, J. Philip Creamer, Luca Malcovati, Sergei Doulatov

Blood (2021) 138 (Supplement 1): 149.

https://doi.org/10.1182/blood-2021-151619

Published: 2021

Journal Articles

Incidence and prognosis of clonal hematopoiesis in patients with chronic idiopathic neutropenia

Grigorios Tsaknakis, Anna Gallì, Stavros Papadakis, Peggy Kanellou, Chiara Elena, Gabriele Todisco, Elisa Bono, Ettore Rizzo, Elisabetta Molteni, Irene Fragiadaki, Irene Mavroudi, Charalampos Pontikoglou, Anastasios Batas, Stella Maxouri, Emmanouela Linardaki, Nektarios Tavernarakis, Luca Malcovati, Helen A. Papadaki

Blood (2021) 138 (14): 1249–1257.

https://doi.org/10.1182/blood.2021010815

Published: 2021

Includes: Supplemental data

Journal Articles

Relationship between clone metrics and clinical outcome in clonal cytopenia

Blood (2021) 138 (11): 965–976.

https://doi.org/10.1182/blood.2021011323

Published: 2021

Includes: Supplemental data

Journal Articles

Genotype-Phenotype Correlations in Patients with Myeloid Malignancies Using Explainable Artificial Intelligence

Nathan Radakovich, BA, Luca Malcovati, MD, Manja Meggendorfer, PhD, Mikkael A. Sekeres, MD MS, Jacob Shreve, MD MS, Cameron Beau Hilton, MD, Yazan Rouphail, Wencke Walter, PhD, Stephan Hutter, PhD, Anna Gallì, Sarah Pozzi, Aaron T. Gerds, MDMS, Sudipto Mukherjee, MD PhD MPH, Cassandra M Kerr, MS, Babal K. Jha, PhD, Claudia Haferlach, MD, Jaroslaw P. Maciejewski, MD PhD, Torsten Haferlach, MD, Aziz Nazha, MD

Blood (2020) 136 (Supplement 1): 31–32.

https://doi.org/10.1182/blood-2020-140023

Published: 2020

Journal Articles

A Personalized Clinical-Decision Tool to Improve the Diagnostic Accuracy of Myelodysplastic Syndromes

Blood (2020) 136 (Supplement 1): 33–35.

https://doi.org/10.1182/blood-2020-139412

Published: 2020

Journal Articles

Gene expression and risk of leukemic transformation in myelodysplasia

Yusuke Shiozawa, Luca Malcovati, Anna Gallì, Andrea Pellagatti, Mohsen Karimi, Aiko Sato-Otsubo, Yusuke Sato, Hiromichi Suzuki, Tetsuichi Yoshizato, Kenichi Yoshida, Yuichi Shiraishi, Kenichi Chiba, Hideki Makishima, Jacqueline Boultwood, Eva Hellström-Lindberg, Satoru Miyano, Mario Cazzola, Seishi Ogawa

Blood (2017) 130 (24): 2642–2653.

https://doi.org/10.1182/blood-2017-05-783050

Published: 2017

Includes: Supplemental data

Journal Articles

Hypoplastic Myelodysplastic Syndrome: Clinical, Histopathological and Molecular Characterization

ELISA Bono, MD, Donal McLornan, Erica Travaglino, Shreyans Gandhi, MBBS,MDMNAMS, Anna Gallì, Alesia Abigael Khan, Austin G. Kulasekararaj, MBBS, MD MRCP, FRCPath, Emanuela Boveri, Kavita Raj, Chiara Elena, Robin M. Ireland, FRCP, Antonio Bianchessi, Jie Jiang, Gabriele Todisco, Luca Malcovati, MD, Judith Marsh, MD, Mario Cazzola, MD, Ghulam Mufti, DM, FRCP, FRCPath

Blood (2017) 130 (Supplement 1): 588.

https://doi.org/10.1182/blood.V130.Suppl_1.588.588

Published: 2017

Journal Articles

Prevalence of Clonal Hematopoiesis and Mutation Patterns in Unexplained Anemia of Community-Dwelling Elderly Individuals: A Case-Control Study

Luca Malcovati, MD, Anna Gallì, Cinzia F Sala, Ettore Rizzo, Elisabetta Molteni, Silvia Zibellini, Eulalia Catamo, Erica Travaglino, Silvia Catricalà, Chiara Elena, Gabriele Todisco, ELISA Bono, MD, Antonio Bianchessi, Virginia Valeria Ferretti, Paolo Gasparini, Clara Camaschella, MD, Daniela Toniolo, Mario Cazzola, MD

Blood (2017) 130 (Supplement 1): 1684.

https://doi.org/10.1182/blood.V130.Suppl_1.1684.1684

Published: 2017

Journal Articles

Clinical significance of somatic mutation in unexplained blood cytopenia

Blood (2017) 129 (25): 3371–3378.

https://doi.org/10.1182/blood-2017-01-763425

Published: 2017

Includes: Supplemental data

Journal Articles

SRSF2 Mutations Identify a Distinct Subtype of Myeloid Neoplasm Across Myelodysplastic Syndromes and Acute Myeloid Leukemia

Gabriele Todisco, MD, Anna Gallì, Erica Travaglino, Ettore Rizzo, Elisabetta Molteni, Chiara Elena, MD, Ilaria Ambaglio, MD, Silvia Catricalà, Paolo Bernasconi, MD, Virginia Valeria Ferretti, Luca Malcovati, MD, Mario Cazzola, MD

Blood (2016) 128 (22): 4337.

https://doi.org/10.1182/blood.V128.22.4337.4337

Published: 2016

Journal Articles

Predictive Value of Mutation Analysis in the Diagnostic Approach to Patients with Unexplained Cytopenia

Luca Malcovati, MD, Anna Gallì, Erica Travaglino, Ilaria Ambaglio, MD, Ettore Rizzo, Elisabetta Molteni, Chiara Elena, MD, Silvia Catricalà, Elisa Bono, MD, Antonio Bianchessi, MD, Gabriele Todisco, MD, Elisa Rumi, MD, Virginia Valeria Ferretti, Elli Papaemmanuil, PhD, Seishi Ogawa, MD PhD, Mario Cazzola, MD

Blood (2016) 128 (22): 298.

https://doi.org/10.1182/blood.V128.22.298.298

Published: 2016

Journal Articles

Targeted Next Generation Sequencing Identifies Novel Genetic Mutations in Patients with Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma or IgM-Monoclonal Gammopathies of Undetermined Significance

Marzia Varettoni, Silvia Zibellini, Ettore Rizzo, Luca Malcovati, MD, Virginia Valeria Ferretti, Matteo Giovanni Della Porta, Anna Gallì, Luca Arcaini, Irene Defrancesco, Mario Cazzola

Blood (2016) 128 (22): 2928.

https://doi.org/10.1182/blood.V128.22.2928.2928

Published: 2016

Journal Articles

Somatic Mutations Are Frequently Detected in Chronic Myeloid Leukemia in Chronic Phase and Do Not Affect Response to Tyrosine-Kinase Inhibitors

Chiara Elena, MD, Anna Gallì, Antonio Bianchessi, Virginia Valeria Ferretti, PhD, Silvia Zibellini, Silvia Catricalà, Celeste Calvello, Barbara Rocca, Paolo Bernasconi, MD, Ettore Rizzo, Elisabetta Molteni, Luca Malcovati, MD, Matteo Giovanni Della Porta, Ester Maria Orlandi, MD, Mario Cazzola, MD

Blood (2016) 128 (22): 1117.

https://doi.org/10.1182/blood.V128.22.1117.1117

Published: 2016

Journal Articles

Combined DNA and Transcriptome Sequencing Reveals Discrete Subtypes of Myelodysplasia

Yusuke Shiozawa, MD, Luca Malcovati, MD, Anna Gallì, Andrea Pellagatti, PhD, Hiromichi Suzuki, MD PhD, Tetsuichi Yoshizato, MD PhD, Yusuke Sato, MD PhD, Keisuke Kataoka, MD PhD, Kenichi Yoshida, MD PhD, Kenichi Yoshida, MD PhD, Masashi Sanada, MD PhD, Hideki Makishima, MD PhD FACP, Yuichi Shiraishi, PhD, Kenichi Chiba, BA, Satoru Miyano, PhD, Jacqueline Boultwood, PhD, Eva Hellström-Lindberg, MD PhD, Seishi Ogawa, MD PhD, Mario Cazzola, MD

Blood (2016) 128 (22): 1974.

https://doi.org/10.1182/blood.V128.22.1974.1974

Published: 2016

NARROW

Risk prediction for clonal cytopenia: multicenter real-world evidence

iPSC Reprogramming Identifies the Role of Cryptic Drivers in Preleukemic Clonal Evolution

Mitotic Dysregulation Sensitizes Malignant Stem Cells to CHK1 Inhibition in SF3B1 -Mutant Myeloid Neoplasms

Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity

Clonal Trajectories and Therapeutic Targeting of High-Risk SF3B1 -Mutant Myelodysplastic Syndromes

Follow-up Next Generation Sequencing (NGS) Analyses on Clonal Chronic Idiopathic Neutropenia (CIN) Patients: Insights in the Natural History of the Disease

Modeling Clonal Progression in SF3B1 -Mutant Myelodysplastic Syndrome

Incidence and prognosis of clonal hematopoiesis in patients with chronic idiopathic neutropenia

Relationship between clone metrics and clinical outcome in clonal cytopenia

Genotype-Phenotype Correlations in Patients with Myeloid Malignancies Using Explainable Artificial Intelligence

A Personalized Clinical-Decision Tool to Improve the Diagnostic Accuracy of Myelodysplastic Syndromes

Gene expression and risk of leukemic transformation in myelodysplasia

Hypoplastic Myelodysplastic Syndrome: Clinical, Histopathological and Molecular Characterization

Prevalence of Clonal Hematopoiesis and Mutation Patterns in Unexplained Anemia of Community-Dwelling Elderly Individuals: A Case-Control Study

Clinical significance of somatic mutation in unexplained blood cytopenia

SRSF2 Mutations Identify a Distinct Subtype of Myeloid Neoplasm Across Myelodysplastic Syndromes and Acute Myeloid Leukemia

Predictive Value of Mutation Analysis in the Diagnostic Approach to Patients with Unexplained Cytopenia

Targeted Next Generation Sequencing Identifies Novel Genetic Mutations in Patients with Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma or IgM-Monoclonal Gammopathies of Undetermined Significance

Somatic Mutations Are Frequently Detected in Chronic Myeloid Leukemia in Chronic Phase and Do Not Affect Response to Tyrosine-Kinase Inhibitors

Combined DNA and Transcriptome Sequencing Reveals Discrete Subtypes of Myelodysplasia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only